Allstate (NYSE:ALL – Get Free Report) announced that its Board of Directors has approved a share buyback plan on Wednesday, February 26th, RTT News reports. The company plans to buyback $1.50 billion in outstanding shares. This buyback authorization allows the insurance provider to purchase up to 3% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s management believes its stock is undervalued.
Allstate Stock Performance
Shares of NYSE:ALL opened at $195.01 on Friday. The company has a current ratio of 0.36, a quick ratio of 0.40 and a debt-to-equity ratio of 0.42. The company has a market cap of $51.64 billion, a price-to-earnings ratio of 11.48, a price-to-earnings-growth ratio of 1.01 and a beta of 0.52. Allstate has a 12 month low of $153.87 and a 12 month high of $209.88. The company has a 50-day moving average price of $190.15 and a 200-day moving average price of $190.71.
Allstate (NYSE:ALL – Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. As a group, equities analysts anticipate that Allstate will post 18.74 EPS for the current year.
Allstate Increases Dividend
Analyst Ratings Changes
A number of brokerages have recently issued reports on ALL. Morgan Stanley increased their price target on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a report on Thursday, November 7th. Evercore ISI raised Allstate from an “in-line” rating to an “outperform” rating in a report on Wednesday, January 8th. Barclays cut their price objective on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a report on Monday, January 6th. Wells Fargo & Company raised their target price on shares of Allstate from $186.00 to $187.00 and gave the company an “equal weight” rating in a research note on Tuesday, January 14th. Finally, UBS Group boosted their price target on shares of Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. One research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Allstate currently has a consensus rating of “Moderate Buy” and a consensus target price of $217.94.
Check Out Our Latest Research Report on ALL
Insider Buying and Selling at Allstate
In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $186.53, for a total value of $7,480,226.06. Following the completion of the transaction, the chief financial officer now directly owns 18,115 shares in the company, valued at $3,378,990.95. This trade represents a 68.88 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.80% of the company’s stock.
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- 5 discounted opportunities for dividend growth investors
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- Buy P&G Now, Before It Sets A New All-Time High
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- Industrial Products Stocks Investing
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.